CA2088975A1 - Composition stable de doxorubicine et de liposomes - Google Patents

Composition stable de doxorubicine et de liposomes

Info

Publication number
CA2088975A1
CA2088975A1 CA002088975A CA2088975A CA2088975A1 CA 2088975 A1 CA2088975 A1 CA 2088975A1 CA 002088975 A CA002088975 A CA 002088975A CA 2088975 A CA2088975 A CA 2088975A CA 2088975 A1 CA2088975 A1 CA 2088975A1
Authority
CA
Canada
Prior art keywords
doxorubicin
composition
suspension
liposome
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002088975A
Other languages
English (en)
Inventor
Anthony H. Huang
Robert Abra
Richard E. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liposome Technology Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2088975A1 publication Critical patent/CA2088975A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002088975A 1990-08-08 1991-08-02 Composition stable de doxorubicine et de liposomes Abandoned CA2088975A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56407090A 1990-08-08 1990-08-08
US564,070 1990-08-08

Publications (1)

Publication Number Publication Date
CA2088975A1 true CA2088975A1 (fr) 1992-02-09

Family

ID=24253045

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002088975A Abandoned CA2088975A1 (fr) 1990-08-08 1991-08-02 Composition stable de doxorubicine et de liposomes

Country Status (5)

Country Link
EP (1) EP0543871A1 (fr)
JP (1) JPH06502623A (fr)
AU (1) AU8329391A (fr)
CA (1) CA2088975A1 (fr)
WO (1) WO1992002208A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU700833B2 (en) * 1991-12-02 1999-01-14 Merial Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained
BE1006379A3 (fr) * 1992-11-26 1994-08-09 Raymond Gilles Procede de conservation de cellules vivantes, d'ensembles de cellules et/ou de derives de ces cellules par lyophilisation.
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
ES2186484B1 (es) 2000-10-10 2004-07-01 Lipotec, S.A. Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos.
PL2081551T3 (pl) * 2006-10-06 2013-06-28 Scil Tech Gmbh Wytworzenie wysuszonego rekonstytuowanego pęcherzyka do zastosowania farmaceutycznego
PL226015B1 (pl) 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension

Also Published As

Publication number Publication date
AU8329391A (en) 1992-03-02
EP0543871A1 (fr) 1993-06-02
WO1992002208A1 (fr) 1992-02-20
JPH06502623A (ja) 1994-03-24

Similar Documents

Publication Publication Date Title
US4927571A (en) Preparation of injectable doxorubicin/liposome suspension
JP2958774B2 (ja) アンホテリシンｂリポソームの改良調整法
CA2505520C (fr) Preparations liposomales d'agents pharmaceutiques stabilisees par des proteines
US4766046A (en) Stabilized liposome/amphotericin composition and method
US4844904A (en) Liposome composition
EP3142656B1 (fr) Formulations de liposomes multivésiculaires d'acide tranexamique
CA2221341C (fr) Suspensions liposomales submicroniques obtenues a partir de lyophilisats preliposomaux
CA1335349C (fr) Composition liposomale et sa production
Cruz et al. Liposomal L-asparaginase: in vitro evaluation
US8298573B2 (en) Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
CN102525927B (zh) 一种醋酸奥曲肽制剂及制备方法
US20060030578A1 (en) Pharmaceutically active lipid based formulation of irinotecan
CA2088975A1 (fr) Composition stable de doxorubicine et de liposomes
KR20200136990A (ko) 서방형 마취제 조성물 및 이의 제조 방법
US5180713A (en) Stabilized liposome/amphotercin B composition and method
US20050129750A1 (en) Process for producing liposome suspension and product containing liposome suspension produced thereby
CA3032687A1 (fr) Compose liposomale contenant un agent actif acide doux
JPH06183954A (ja) リポソーム製剤
US20040175417A1 (en) Amphotericin B liposome preparation
CN115737565B (zh) 一种五味子乙素脂质体及其制备方法
JPH0114A (ja) リポソーム製剤およびその製造法
WO1993023016A1 (fr) Formulations de liposomes contenant des rifamycines
CN114668723A (zh) 一种含有局部麻醉药的脂质体及其制备方法
NO890097L (no) Liposom/doksorubicin-sammensetning og fremgangsmaate.
KR20020011993A (ko) 미소한 리포좀 및 그 제조 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead